Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306804950> ?p ?o ?g. }
- W4306804950 endingPage "109729" @default.
- W4306804950 startingPage "109729" @default.
- W4306804950 abstract "The activation of phagocytic cells is a hallmark of many neurological diseases. Imaging them in their 3-dimensional cerebral environment over time is crucial to better understand their role in disease pathogenesis and to monitor their potential therapeutic effects. Phagocytic cells have the ability to internalize metal-based contrast agents both in vitro and in vivo and can thus be tracked by magnetic resonance imaging (MRI) or computed tomography (CT). In this review article, we summarize the different labelling strategies, contrast agents, and in vivo imaging modalities that can be used to monitor cells with phagocytic activity in the central nervous system using MRI and CT, with a focus on clinical applications. Metal-based nanoparticle contrast agents such as gadolinium, gold and iron are ideal candidates for these applications as they have favourable magnetic and/or radiopaque properties and can be fine-tuned for optimal uptake by phagocytic cells. However, they also come with downsides due to their potential toxicity, especially in the brain where they might accumulate. We therefore conclude our review by discussing the pitfalls, safety and potential for clinical translation of these metal-based neuroimaging techniques. Early results in patients with neuropathologies such as multiple sclerosis, stroke, trauma, cerebral aneurysm and glioblastoma are promising. If the challenges represented by safety issues are overcome, phagocytic cells imaging will be a very valuable tool for studying and understanding the inflammatory response and evaluating treatments that aim at mitigating this response in patients with neurological diseases." @default.
- W4306804950 created "2022-10-20" @default.
- W4306804950 creator A5003020683 @default.
- W4306804950 creator A5003241246 @default.
- W4306804950 creator A5004502841 @default.
- W4306804950 creator A5005654121 @default.
- W4306804950 creator A5018435605 @default.
- W4306804950 creator A5032578646 @default.
- W4306804950 creator A5046429548 @default.
- W4306804950 creator A5050373271 @default.
- W4306804950 creator A5051623571 @default.
- W4306804950 creator A5054881104 @default.
- W4306804950 creator A5060920591 @default.
- W4306804950 creator A5067440768 @default.
- W4306804950 creator A5089510795 @default.
- W4306804950 date "2023-01-01" @default.
- W4306804950 modified "2023-10-17" @default.
- W4306804950 title "Use of metal-based contrast agents for in vivo MR and CT imaging of phagocytic cells in neurological pathologies" @default.
- W4306804950 cites W1825325706 @default.
- W4306804950 cites W1873080789 @default.
- W4306804950 cites W1961744561 @default.
- W4306804950 cites W1964020449 @default.
- W4306804950 cites W1969090531 @default.
- W4306804950 cites W1979216323 @default.
- W4306804950 cites W1991392994 @default.
- W4306804950 cites W1992693587 @default.
- W4306804950 cites W2006858976 @default.
- W4306804950 cites W2014582194 @default.
- W4306804950 cites W2016715030 @default.
- W4306804950 cites W2019268848 @default.
- W4306804950 cites W2019287029 @default.
- W4306804950 cites W2020177177 @default.
- W4306804950 cites W2026101545 @default.
- W4306804950 cites W2050408401 @default.
- W4306804950 cites W2053997075 @default.
- W4306804950 cites W2058027038 @default.
- W4306804950 cites W2059221778 @default.
- W4306804950 cites W2069477235 @default.
- W4306804950 cites W2070589883 @default.
- W4306804950 cites W2072260099 @default.
- W4306804950 cites W2075965904 @default.
- W4306804950 cites W2079574023 @default.
- W4306804950 cites W2080806462 @default.
- W4306804950 cites W2083366748 @default.
- W4306804950 cites W2085490428 @default.
- W4306804950 cites W2088895984 @default.
- W4306804950 cites W2091319224 @default.
- W4306804950 cites W2095671347 @default.
- W4306804950 cites W2109030151 @default.
- W4306804950 cites W2118509922 @default.
- W4306804950 cites W2121341823 @default.
- W4306804950 cites W2125153103 @default.
- W4306804950 cites W2126863379 @default.
- W4306804950 cites W2130767350 @default.
- W4306804950 cites W2131606207 @default.
- W4306804950 cites W2135728677 @default.
- W4306804950 cites W2153284686 @default.
- W4306804950 cites W2153310303 @default.
- W4306804950 cites W2154155058 @default.
- W4306804950 cites W2156969855 @default.
- W4306804950 cites W2165693138 @default.
- W4306804950 cites W2170698863 @default.
- W4306804950 cites W2182603165 @default.
- W4306804950 cites W2195136380 @default.
- W4306804950 cites W2233704955 @default.
- W4306804950 cites W2313203336 @default.
- W4306804950 cites W2314634699 @default.
- W4306804950 cites W2316559971 @default.
- W4306804950 cites W2327992815 @default.
- W4306804950 cites W2334920443 @default.
- W4306804950 cites W2404905432 @default.
- W4306804950 cites W2412405311 @default.
- W4306804950 cites W2414102005 @default.
- W4306804950 cites W2416755357 @default.
- W4306804950 cites W2418720770 @default.
- W4306804950 cites W2421934414 @default.
- W4306804950 cites W2427645657 @default.
- W4306804950 cites W2433010802 @default.
- W4306804950 cites W2515087066 @default.
- W4306804950 cites W2527636586 @default.
- W4306804950 cites W2528096704 @default.
- W4306804950 cites W2528228860 @default.
- W4306804950 cites W2540248011 @default.
- W4306804950 cites W2555101073 @default.
- W4306804950 cites W2561872017 @default.
- W4306804950 cites W2607015440 @default.
- W4306804950 cites W2608469195 @default.
- W4306804950 cites W2619488828 @default.
- W4306804950 cites W272355628 @default.
- W4306804950 cites W2746427115 @default.
- W4306804950 cites W2748918690 @default.
- W4306804950 cites W2792889768 @default.
- W4306804950 cites W2808295841 @default.
- W4306804950 cites W2811295997 @default.
- W4306804950 cites W2886474693 @default.
- W4306804950 cites W2890406085 @default.
- W4306804950 cites W2896682297 @default.
- W4306804950 cites W2900225902 @default.